Coronary artery stenosis detection with 64-slice CT can get a boost in accuracy if intravenous contrast protocols aim for maximum intravascular attenuation, according to research presented today at the American Roentgen Ray Society meeting in Orlando.
Coronary artery stenosis detection with 64-slice CT can get a big boost in accuracy if intravenous contrast protocols aim for maximum intravascular attenuation, according to research presented today at the American Roentgen Ray Society meeting in Orlando.
Researchers from the Erasmus Medical Center in Rotterdam, the Netherlands, and Azienda Ospedaliero-Universitaria in Parma, Italy, found that high-attenuation protocols yield a sensitivity and specificity of 96.3% and 97.6%, compared with 82.8% and 93.2%, respectively, for low-attenuation protocols.
High attenuation was particularly useful for evaluation of distal segments, said Dr. Erica Maffei of the Azienda Ospedaliero-Universitaria, who presented the results.
The European study involved 170 patients with known or suspected artery disease who were scheduled to undergo conventional angiography. All patients first underwent CTA on a Philips Brilliance Pro 64-slice unit. Significant stenosis was defined as reduction of the lumen by at least 50%.
Patient groups were similar in body mass index, coronary calcium score, heart rate, and age. Half had low-attenuation protocols (average intracoronary attenuation, 297), and half had high attenuation (average intracoronary attenuation, 388).
Of 2050 segments evaluated, coronary angiography found 323 significant lesions.
"Sensitivity and specificity are significantly higher with high attenuation than low attenuation. Contrast material administration protocols should aim at higher intravascular iodine concentration," Maffei said.
"High attentuation is not as common as it should be. Most people think that intermediate attenuation is fine. Instead, a high intracoronary attenuation is the goal for better diagnostic accuracy," said lead author Dr. Filippo Cademartiri of the Azienda Ospedaliero-Universitaria.
In a study from the U.S. presented during the same session, Thomas Jefferson University researchers obtained excellent results with 64-slice CT in assessment of coronary artery disease.
Significant disease was defined as more than a 50% reduction in the diameter of the lumen. In the study, 57 patients underwent cardiac-gated CTA and then proceeded to undergo conventional angiography within one month.
Images were assessed in a double-blind fashion. Of 855 segments, significant stenosis was found in 96 (57 patients evaluated) on coronary CTA. Coronary angiography revealed that 23 cases had been underestimated or overestimated by CTA and only 73 had significant stenosis.
Results with CTA were as follows:
"Our study demonstrates that coronary CTA using MSCT is an excellent noninvasive method of detecting significant artery disease, with high accuracy compared with basic angiography," said Dr. Shaoxiong Zhang, an assistant professor of radiology at Jefferson, who presented study results.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.